AI Science Tracker
EN

Using Machine Learning Imputed Outcomes to Assess Drug-Dependent Risk of Self-Harm in Patients with Bipolar Disorder: A Comparative Effectiveness Study.

Center for Global Health, University of New Mexico Health Sciences Center; University of New Mexico Department of Computer Science · 21 Apr 2021 · medicine

Discovery

Using Machine Learning Imputed Outcomes to Assess Drug-Dependent Risk of Self-Harm in Patients with Bipolar Disorder: A Comparative Effectiveness Study.

Source check: Source checked. Not independent scientific confirmation.

Finding: The study used a retrospective claims cohort of approximately 1.3 million patients, cross-validated imputation, and compared drug-dependent self-harm risk. Conclusions depend on the imputation model and claims-derived outcomes; the study does not directly observe all self-harm events.

Technology: Machine-learning imputation estimated uncoded self-harm outcomes in a large bipolar-disorder claims cohort and supported comparative drug-risk analyses.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning imputation estimated uncoded self-harm outcomes in a large bipolar-disorder claims cohort and supported comparative drug-risk analyses.
Test and result
The study used a retrospective claims cohort of approximately 1.3 million patients, cross-validated imputation, and compared drug-dependent self-harm risk.
Limitation / still unknown
Conclusions depend on the imputation model and claims-derived outcomes; the study does not directly observe all self-harm events.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8100888/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.